Published in Biochem Biophys Res Commun on December 17, 2004
Cleavable ErbB4 isoform in estrogen receptor-regulated growth of breast cancer cells. Cancer Res (2005) 1.93
Inhibition of cancer cell growth by crude extract and the phenolics of Terminalia chebula retz. fruit. J Ethnopharmacol (2002) 1.58
Association of low 25-hydroxyvitamin D concentrations with elevated parathyroid hormone concentrations and low cortical bone density in early pubertal and prepubertal Finnish girls. Am J Clin Nutr (2003) 1.55
The Wnt-5a-derived hexapeptide Foxy-5 inhibits breast cancer metastasis in vivo by targeting cell motility. Clin Cancer Res (2008) 1.28
Panel discussion does not improve reliability of peer review for medical research grant proposals. J Clin Epidemiol (2011) 1.24
Tamoxifen-induced rapid death of MCF-7 breast cancer cells is mediated via extracellularly signal-regulated kinase signaling and can be abrogated by estrogen. Endocrinology (2007) 1.21
Multiple cellular mechanisms related to cyclin A1 in prostate cancer invasion and metastasis. J Natl Cancer Inst (2008) 1.18
FGF-8 is involved in bone metastasis of prostate cancer. Int J Cancer (2008) 1.13
Effect of impact exercise on bone mineral density in elderly women with low BMD: a population-based randomized controlled 30-month intervention. Osteoporos Int (2005) 1.07
Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw: Is there a diverse relationship of amino- and non-aminobisphosphonates? Crit Rev Oncol Hematol (2007) 1.03
Down-regulation of the oncogene cyclin D1 increases migratory capacity in breast cancer and is linked to unfavorable prognostic features. Am J Pathol (2010) 1.02
MicroRNAs regulate osteogenesis and chondrogenesis of mouse bone marrow stromal cells. Gene Regul Syst Bio (2008) 0.99
Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer. Breast Cancer Res Treat (2012) 0.98
Inactivation of estrogen receptor α in bone-forming cells induces bone loss in female mice. FASEB J (2012) 0.98
Effects of ospemifene and raloxifene on hormonal status, lipids, genital tract, and tolerability in postmenopausal women. Menopause (2005) 0.93
Effects of ospemifene and raloxifene on biochemical markers of bone turnover in postmenopausal women. J Bone Miner Metab (2006) 0.93
Effects of Lactobacillus helveticus fermented milk on bone cells in vitro. Life Sci (2004) 0.92
Estrogen responsiveness of bone formation in vitro and altered bone phenotype in aged estrogen receptor-alpha-deficient male and female mice. Eur J Endocrinol (2005) 0.91
Alendronate disturbs vesicular trafficking in osteoclasts. Calcif Tissue Int (2001) 0.91
68Ga-chloride PET reveals human pancreatic adenocarcinoma xenografts in rats--comparison with FDG. Mol Imaging Biol (2009) 0.91
Tracer level electrophilic synthesis and pharmacokinetics of the hypoxia tracer [(18)F]EF5. Mol Imaging Biol (2012) 0.90
Osteoclasts in neurofibromatosis type 1 display enhanced resorption capacity, aberrant morphology, and resistance to serum deprivation. Bone (2010) 0.90
Alendronate decreases orthotopic PC-3 prostate tumor growth and metastasis to prostate-draining lymph nodes in nude mice. BMC Cancer (2008) 0.90
68Ga-labeled oligonucleotides for in vivo imaging with PET. J Nucl Med (2004) 0.90
Overexpression of vascular endothelial growth factor C increases growth and alters the metastatic pattern of orthotopic PC-3 prostate tumors. BMC Cancer (2009) 0.89
Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells. Mol Cell Endocrinol (2008) 0.88
In vitro bioactivity-guided fractionation and characterization of polyphenolic inhibitory fractions from Acacia nilotica (L.) Willd. ex Del. J Ethnopharmacol (2005) 0.85
Inhibition of cyclooxygenase-2 down-regulates osteoclast and osteoblast differentiation and favours adipocyte formation in vitro. Eur J Pharmacol (2007) 0.85
Long-term outcomes of exercise: follow-up of a randomized trial in older women with osteopenia. Arch Intern Med (2010) 0.85
Low expression of SHP-2 is associated with less favorable prostate cancer outcomes. Tumour Biol (2012) 0.84
Effects of estradiol and medroxyprogesterone acetate on morphology, proliferation and apoptosis of human breast tissue in organ cultures. BMC Cancer (2006) 0.84
Cyclin A1 modulates the expression of vascular endothelial growth factor and promotes hormone-dependent growth and angiogenesis of breast cancer. PLoS One (2013) 0.84
Periapical cemental dysplasia is common in women with NF1. Eur J Med Genet (2007) 0.84
Serum myoglobin/carbonic anhydrase III ratio in the diagnosis of perioperative myocardial infarction during coronary bypass surgery. Scand Cardiovasc J (2003) 0.83
Role of the protein tyrosine phosphatase SHP-1 in Interleukin-6 regulation of prostate cancer cells. Prostate (2010) 0.82
A highly conserved protein secreted by the prostate cancer cell line PC-3 is expressed in benign and malignant prostate tissue. Biol Chem (2007) 0.82
Immunohistochemical detection of tyrosine phosphatase SHP-1 predicts outcome after radical prostatectomy for localized prostate cancer. Int J Cancer (2010) 0.81
Effect of exercise on extraskeletal risk factors for hip fractures in elderly women with low BMD: a population-based randomized controlled trial. J Bone Miner Res (2006) 0.81
Interaction of spin-labeled inhibitors of the vacuolar H+-ATPase with the transmembrane Vo-sector. Biophys J (2007) 0.80
Effects of estradiol and medroxyprogesterone acetate on expression of the cell cycle proteins cyclin D1, p21 and p27 in cultured human breast tissues. Cell Cycle (2007) 0.80
Fibroblast growth factor 8b causes progressive stromal and epithelial changes in the epididymis and degeneration of the seminiferous epithelium in the testis of transgenic mice. Biol Reprod (2012) 0.80
Androgens inhibit the stimulatory action of 17β-estradiol on normal human breast tissue in explant cultures. J Clin Endocrinol Metab (2012) 0.80
Fibroblast growth factor 8 induced downregulation of thrombospondin 1 is mediated by the MEK/ERK and PI3K pathways in breast cancer cells. Growth Factors (2010) 0.79
Serum myoglobin/carbonic anhydrase III ratio as a marker of reperfusion after myocardial infarction. Int J Cardiol (2003) 0.78
Attempt to treat congenital pseudarthrosis of the tibia with mesenchymal stromal cell transplantation. Cytotherapy (2010) 0.77
Total and carboxylated osteocalcin associate with insulin levels in young adults born with normal or very low birth weight. PLoS One (2013) 0.77
Sex specific expression of progesterone receptor in mouse lower urinary tract. Mol Cell Endocrinol (2005) 0.77
Osteoclasts derived from patients with neurofibromatosis 1 (NF1) display insensitivity to bisphosphonates in vitro. Bone (2011) 0.77
Effects of bioactive peptide, valyl-prolyl-proline (VPP), and lactobacillus helveticus fermented milk containing VPP on bone loss in ovariectomized rats. Ann Nutr Metab (2007) 0.77
Serum osteocalcin in relation to calcaneal bone mineral density in elderly men and women: a 5-year follow-up. J Bone Miner Metab (2002) 0.76
Phenotypic characterization of transgenic mice harboring Nf1+/- or Nf1-/- osteoclasts in otherwise Nf1+/+ background. J Cell Biochem (2012) 0.76
Editorial comment on: expression and prognostic relevance of annexin A3 in prostate cancer. Eur Urol (2008) 0.75
Editorial comment on: stem cell characteristics in prostate cancer cell lines. Eur Urol (2009) 0.75
Multiparametric luminescence method for quantitative cell surface protein expression analysis and imaging. J Immunol Methods (2011) 0.75
Neurofibromatosis 1-related osteopenia often progresses to osteoporosis in 12 years. Calcif Tissue Int (2012) 0.75
Effects of ospemifene, a novel selective estrogen-receptor modulator, on human breast tissue ex vivo. Menopause (2016) 0.75